Litcius/Paper detail

Quantification of nivolumab in human plasma by LC-MS/HRMS and LC-MS/MS, comparison with ELISA

Aurélien Millet, Nihel Khoudour, Pauline Bros, Dorothée Lebert, Guillaume Picard, Christelle Machon, François Goldwasser, Benoı̂t Blanchet, Jérôme Guitton

2020Talanta40 citationsDOIOpen Access PDF

Topics & Concepts

ChemistryChromatographyOrbitrapNivolumabMass spectrometryTandem mass spectrometryLiquid chromatography–mass spectrometryTriple quadrupole mass spectrometerSelected reaction monitoringCancerImmunotherapyMedicineInternal medicineCancer Immunotherapy and BiomarkersBiosimilars and Bioanalytical MethodsMonoclonal and Polyclonal Antibodies Research
Quantification of nivolumab in human plasma by LC-MS/HRMS and LC-MS/MS, comparison with ELISA | Litcius